Miragen Therapeutics reports Q2 results

  • Miragen Therapeutics (MGEN): Q2 EPS of -$0.34
  • Revenue of $0.72M (-34.5% Y/Y)
  • Press Release

Recommended For You

More Trending News

About VRDN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VRDN--
Viridian Therapeutics, Inc.